University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 3C-13-2


A Pilot Study of Monitoring Metastatic Colorectal Cancers with Liquid Biopsies.

Type: Other
Phase: Pilot
Status: Open to Accrual
Treatments:
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Afsaneh Barzi, M.D.
Other Trial Staff:  Ramona Lujan, R.N., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Noureddine Miloud, D.M.

Staff may log in to see study documents.


You may participate in this study if:
 Requirement
1Histologically confirmed metastatic or unresectable colorectal cancer with known Kras status who will undergo first-line therapy. Knowledge of other mutations is optional. Participating investigator will select treatment, however, patients with Kras wild type must receive anti-EGFR therapy to be eligible for this study.
2At least 18 years of age
3Willing to follow study instructions for collection of specimens
4Willing to undergo biopsy at the time of progression
5Available archival tissue
6Signed informed consent


You may not participate in this study if:
1Prior history of treatment for colon cancer



For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.